| ¿µ¹® | alkaline phosphatase | ÇÑ±Û | ¾ËÄ®¸®¼º ÀλêºÐÇØÈ¿¼Ò |
|---|---|---|---|
| ¼³¸í | È¿¼ÒÀÇ ÀÏÁ¾ÀÌ¸ç ¿©·¯ °¡Áö µ¿Á¾È¿¼Ò(±â´ÉÀº °°Áö¸¸ ±¸Á¶°¡ ¾à°£¾¿ ´Ù¸¥ È¿¼ÒÇüÅÂ)·Î ½ÅüÀÇ ¿©·¯ ºÎÀ§(ƯÈ÷ »À¿Í °£)¿¡ Á¤»óÀûÀ¸·Î ¸¹ÀÌ Á¸ÀçÇÑ´Ù. °£³» ¾µ°³°üÀÇ ¼¼Æ÷¿¡ ¸¹ÀÌ Á¸ÀçÇϸç, »À¸¦ »ý¼ºÇÏ´Â ¼¼Æ÷ÀÎ »À¸ð¼¼Æ÷(osteoblast)¿¡ ¸¹ÀÌ Á¸ÀçÇÑ´Ù. ±× ¿Ü¿¡µµ ¿©·¯ ±â°ü¿¡ Á¸ÀçÇÑ´Ù. ÀÓ»óÀû ÀÇÀÇ´Â °£°ú »ÀÀÇ º´ Áø´Ü°ú Ä¡·áÈ¿°ú ÆÇÁ¤¿¡ µµ¿òÀ» ÁØ´Ù. °£, ƯÈ÷ °£¿¡¼ ¸¸µé¾îÁø ´ãÁóÀ» »ùâÀÚ±îÁö ¿î¹ÝÇÏ´Â ¾µ°³±æÀÌ ¸·Èù °æ¿ì(¾µ°³°ü³»¿¡ Á¾¾çÀÌ »ý±â°Å³ª ¾µ°³µ¹ÁõÀ¸·Î ÀÎÇØ¼ ¾µ°³°üÀÌ ¸·Èù °æ¿ì)¿¡´Â ¾µ°³³»ÀÇ ¾Ð·ÂÀÌ ³ô¾ÆÁö°í °£³» ¾µ°³°üÀÇ ¼¼Æ÷°¡ ±úÁ® ±× ¼Ó¿¡ µé¾î ÀÖ´ø ¾ËÄ®¸®¼º ÀλêºÐÇØÈ¿¼Ò°¡ Ç÷¾×¼ÓÀ¸·Î ¹æÃâµÇ¾î Ç÷Áß ¾ËÄ®¸®¼º ÀλêºÐÇØÈ¿¼ÒÀÇ ³óµµ°¡ ³ô¾ÆÁø´Ù. ±×¸®°í »ÀÀÇ »ý¼ºÀÌ ¸¹¾ÆÁö´Â ¸ðµç °æ¿ì(¿¹¸¦ µé¸é °ñÀý, Á¾¾ç¿¡ ÀÇÇÑ »ÀÀÇ ÆÄ±«½Ã º¹±¸¸¦ À§Çؼ »ÀÀÇ »ý¼ºÀÌ Áõ°¡ÇÑ´Ù), »À¸ð¼¼Æ÷ÀÇ È°µ¿ÀÌ Áõ°¡µÇ°í »À¸ð¼¼Æ÷ÀÇ È¿¼ÒÀÎ ¾ËÄ®¸®¼º ÀλêºÐÇØÈ¿¼ÒÀÇ È°¼ºµµ ¿ª½Ã Áõ°¡µÈ´Ù. |
||
| ¿µ¹® | staphylococcal food poisoning | ÇÑ±Û | Æ÷µµ¾Ë±Õ ½ÄÁßµ¶ |
|---|---|---|---|
| ¼³¸í | Å©¸²ÀÌ µé¾î ÀÖ´Â °úÀÚ, Ä¿½ºÅ¸µå(custards), Ä¡Áî¿Í °°Àº ½ÄǰÀ̳ª, À°·ù¿¡ Ȳ»ö Æ÷µµ¾Ë±ÕÀÌ »ý¼ºÇϴ âÀÚ°üµ¶ÀÌ ÇÔÀ¯µÈ °ÍÀ» ¼·ÃëÇÏ¿© ÀϾ´Â ½ÄÁßµ¶À¸·Î¼ °©ÀÛ½º·¯¿î ¹ßº´, µÎÅë, ħºÐºñ, ±¸¿ª, ±¸Åä, ¼³»ç, º¹ºÎ»êÅë ¹× ¶¡³²À» Ư¡À¸·Î Çϸç, ¹ßÀÛ ÈÄ 5~6½Ã°£ Áö¼ÓÇÑ´Ù. |
||
| SE | saline enema; sanitary engineering; side effect; smoke exposure; solid extract; sphenoethmoidal; spi... |
|---|---|
| AP | accessory pathway; accounts payable; acid phosphatase; acinar parenchyma; action potential; active p... |
| APAAP | alkaline phosphatase-antialkaline phosphatase [labeling] |
| NAP | nasion, point A, pogonion [convexity or concavity of the facial profile]; nerve action potential; ne... |
| PAP | pancreatitis-associated protein; Papanicolaou [test]; papaverine; passive-aggressive personality; pa... |
| APAAP | Alkaline Phosphatase anti-Alkaline Phosphatase |
|---|---|
| SE | Staphylococcal enterotoxin |
| SEA | Staphylococcal Enterotoxin A |
| SEB | Staphylococcal Enterotoxin B |
| SNase | Staphylococcal Nuclease |
| Staphylococcal neutral phosphatase | <enzyme> A surface-bound bacterial protein; highly cationic; shows maximum phosphatase activity at neutral pH; binds to immunoglobulin Registry number: EC 3.1.3.- Synonym: staphylococcal nptase, nptase (26 Jun 1999) |
|---|
| pneumonia, staphylococcal | Pneumonia caused by staphylococcus aureus. This condition is a frequent complication of viral influenza. (12 Dec 1998) |
|---|---|
| staphylococcal | Infection due to staphylococcus. (27 Sep 1997) |
| staphylococcal food poisoning | Poisoning by staphylococcal toxins present in contaminated food. (12 Dec 1998) |
| staphylococcal infections | Infections with bacteria of the genus staphylococcus. (12 Dec 1998) |
| staphylococcal pneumonia | Pneumonia, usually caused by Staphylococcus aureus, usually commencing as a bronchopneumonia, and frequently leading to suppuration and destruction of lung tissue. (05 Mar 2000) |
| staphylococcal protein a | A protein present in the cell wall of most staphylococcus aureus strains. The protein selectively binds to the fc region of human normal and myeloma-derived IgG. It elicits antibody activity and may cause hypersensitivity reactions due to histamine release; has also been used as cell surface antigen marker and in the clinical assessment of b lymphocyte function. (12 Dec 1998) |
| staphylococcal scalded skin syndrome | <syndrome> A disease of infants due to group 2 phage type 17 staphylococci that produce an epidermolytic exotoxin. Superficial fine vesicles and bullae form and rupture easily, resulting in loss of large sheets of epidermis. (12 Dec 1998) |
| staphylococcal skin infections | Infections to the skin caused by bacteria of the genus staphylococcus. (12 Dec 1998) |
| Armillaria mellea neutral proteinase | <enzyme> Specific for lysine Registry number: EC 3.4.99.32 (26 Jun 1999) |
| ribosomal neutral proteinase | <enzyme> Ribosomal serine proteinase from rat liver ribosomes in cryptic form Registry number: EC 3.4.21.52 Synonym: cathepsin r (26 Jun 1999) |
| Staphylococcus aureus neutral proteinase | <enzyme> Included in the group of microbial metalloproteinases EC 3.4.24.4; ptrb protein is isolated from E coli; sakstar is recombinant staphylokinase Pharmacological action: fibrinolytic agents Registry number: EC 3.4.24.- Synonym: protease II, staphylokinase, staph aureus protease, staphylococcal protease, E coli protease, ptrb protein, sakstar, (26 Jun 1999) |
| neutral | 1. Not engaged on either side; not taking part with or assisting either of two or more contending parties; neuter; indifferent. "The heart can not possibly remain neutral, but constantly takes part one way or the other." (Shaftesbury) 2. Neither good nor bad; of medium quality; middling; not decided or pronounced. "Some things good, and some things ill, do seem, And neutral some, in her fantastic eye." (Sir J. Davies) 3. <biology> Neuter. See Neuter. 4. <chemistry> Having neither acid nor basic properties; unable to turn red litmus blue or blue litmus red; said of certain salts or other compounds. Contrasted with acid, and alkaline. <chemistry> Neutral axis, Neutral surface, a salt formed by the complete replacement of the hydrogen in an acid or base; in the former case by a positive or basic, in the latter by a negative or acid, element or radical. Neutral tint, a bluish gray pigment, used in water colours, made by mixing indigo or other blue some warm colour. The shades vary greatly. Neutral vowel, the vowel element having an obscure and indefinite quality, such as is commonly taken by the vowel in many unaccented syllables. It is regarded by some as identical with the u in up, and is called also the natural vowel, as unformed by art and effort. Origin: L. Neutralis, fr. Neuter. See Neuter. Source: Websters Dictionary (01 Mar 1998) |
| neutral axis of straight beam | The axis perpendicular to the plane of loading of a beam at stresses within the proportional limit; it lies at the gravity axis of the cross-section of the beam. (05 Mar 2000) |
| neutral beam injection | <radiobiology> This is one of the fundamental plasma heating methods. A particle accelerator is used to create fast ion beams (the particle energies are on the order of 100 keV), the ion beam is then passed through a neutral gas region, where the ions neutralise via charge-exchange reactions with the neutral gas. The neutralised beam is then injected into a magnetically confined plasma. The neutral atoms are unaffected (not confined) by the magnetic field, but ionize as they penetrate into the plasma. The high-energy ions then transfer some of their energy to the plasma particles in repeated collisions, and heat the plasma. (09 Oct 1997) |
| neutral buffered formalin fixative | A general histologic fixative less likely to leave formalin deposits in tissue than formol-saline fixative. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|